In the multivariate analysis, not only were the conventional prognostic factors, including age, number of extracranial metastatic sites, and presence of LMD, associated with the survival from the time of BM, but also both the ER and HER2 status affected survival. The gene discussed is ERBB2; the disease is Langer mesomelic dysplasia.